Pelvic-Restricted vs. Pelvic-Free Robot-Assisted Gait Training in Stroke Patients
Comparison of Pelvic-Free and Pelvic-Restricted Robot-Assisted Gait Training on Walking Pattern, Balance, and Fear of Falling After Stroke
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
This randomized controlled clinical trial aims to compare the effects of pelvic-free versus pelvic-restricted robot-assisted gait training (RAGT) on gait pattern, balance, and fear of falling in stroke patients. Stroke survivors often experience gait impairments, reduced balance, and fear of falling, which limit independence and quality of life. Conventional physiotherapy requires high intensity and repetition but is restricted by therapist capacity. Robotic gait systems provide intensive, repetitive, and safe training; however, most limit pelvic motion, potentially disrupting natural gait patterns and balance strategies. A total of 36 participants with chronic stroke (≥6 months post-stroke, age ≥18 years, hemiplegic gait disorder, Functional Ambulation Category ≥2) will be randomized into two groups: (1) pelvic-free RAGT plus conventional rehabilitation, or (2) pelvic-restricted RAGT plus conventional rehabilitation. Interventions will consist of 8 RAGT sessions (twice weekly) and 20 conventional rehabilitation sessions (five times weekly) over 4 weeks. Primary outcomes include gait analysis parameters (gait speed, step length, cadence, temporal symmetry index) and clinical measures such as the Berg Balance Scale, Functional Ambulation Category, Motricity Index (lower limb), and Falls Efficacy Scale-International. Assessments will be performed at baseline and after 4 weeks of treatment. The study hypothesizes that pelvic-free RAGT will improve gait symmetry, balance, and reduce fear of falling more effectively than pelvic-restricted training. Results are expected to provide evidence supporting the integration of pelvic-free robotic gait systems into post-stroke rehabilitation to enhance functional recovery and patient confidence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jan 2026
Shorter than P25 for not_applicable stroke
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedJanuary 26, 2026
January 1, 2026
3 months
September 26, 2025
January 23, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
Berg Balance Scale
14-item scale assessing static and dynamic balance, scored 0-56 (higher scores indicate better balance).
Baseline (T0) and 4 weeks post-intervention (T1)
Gait Speed
Gait speed will be assessed using the Zebris FDM-T treadmill system and expressed in meters per second (m/s).
Baseline (T0) and 4 weeks post-intervention (T1)
Step Length
Step length will be measured with the Zebris FDM-T treadmill system and reported in centimeters (cm).
Baseline (T0) and 4 weeks post-intervention (T1)
Cadence
Cadence will be recorded using the Zebris FDM-T treadmill system and expressed in steps per minute.
Baseline (T0) and 4 weeks post-intervention (T1)
Double Support Time
Double support time will be assessed with the Zebris FDM-T treadmill system and expressed as percentage (%) of the gait cycle.
Baseline (T0) and 4 weeks post-intervention (T1)
Temporal Symmetry Index
Temporal symmetry index will be calculated from gait analysis with the Zebris FDM-T treadmill system and expressed as a percentage (%).
Baseline (T0) and 4 weeks post-intervention (T1)
Secondary Outcomes (3)
Functional Ambulation Category (FAC)
Baseline (T0) and 4 weeks post-intervention (T1)
Motricity Index - Lower Limb
Baseline (T0) and 4 weeks post-intervention (T1)
Falls Efficacy Scale-International (FES-I)
Baseline (T0) and 4 weeks post-intervention (T1)
Study Arms (2)
Pelvic-Free Robot-Assisted Gait Training + Conventional Rehabilitation
EXPERIMENTALParticipants will receive 8 sessions of pelvic-free robot-assisted gait training with RoboGait® (2 sessions per week for 4 weeks) in addition to conventional rehabilitation (5 sessions per week for 4 weeks).
Pelvic-Restricted Robot-Assisted Gait Training + Conventional Rehabilitation
ACTIVE COMPARATORParticipants will receive 8 sessions of pelvic-restricted robot-assisted gait training with RoboGait® (2 sessions per week for 4 weeks) in addition to conventional rehabilitation (5 sessions per week for 4 weeks).
Interventions
Robot-assisted gait training using the RoboGait® system in pelvic-free mode. Participants receive 8 sessions (2 per week for 4 weeks) in addition to conventional rehabilitation.
Robot-assisted gait training using the RoboGait® system in pelvic-restricted mode. Participants receive 8 sessions (2 per week for 4 weeks) in addition to conventional rehabilitation.
Standard physiotherapy program consisting of 20 sessions (5 per week for 4 weeks) focused on mobility, strengthening, and functional training. Applied to all participants in both groups.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- History of stroke more than 6 months prior
- Presence of hemiplegia-related gait disorder
- Functional Ambulation Category (FAC) score ≥ 2
- Ability to walk independently prior to stroke
You may not qualify if:
- Severe cognitive or communication impairment
- Movement limitations due to joint contracture or deformity
- Presence of open wounds or pressure ulcers
- Uncontrolled hypertension or orthostatic hypotension
- Severe cardiovascular disease, heart failure, cancer, or serious pulmonary disease
- High risk of fracture due to severe osteoporosis
- Gait impairment caused by lower extremity musculoskeletal disorders
- Severe psychosis/neurosis
- Modified Ashworth Scale \> 3 in the lower extremities (severe spasticity)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Lee J, Chun MH, Seo YJ, Lee A, Choi J, Son C. Effects of a lower limb rehabilitation robot with various training modes in patients with stroke: A randomized controlled trial. Medicine (Baltimore). 2022 Nov 4;101(44):e31590. doi: 10.1097/MD.0000000000031590.
PMID: 36343085RESULTAurich-Schuler T, Gut A, Labruyere R. The FreeD module for the Lokomat facilitates a physiological movement pattern in healthy people - a proof of concept study. J Neuroeng Rehabil. 2019 Feb 6;16(1):26. doi: 10.1186/s12984-019-0496-x.
PMID: 30728040RESULTAlingh JF, Weerdesteyn V, Nienhuis B, van Asseldonk EHF, Geurts ACH, Groen BE. Immediate after-effects of robot-assisted gait with pelvic support or pelvic constraint on overground walking in healthy subjects. J Neuroeng Rehabil. 2019 Mar 15;16(1):40. doi: 10.1186/s12984-019-0506-z.
PMID: 30876445RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Physical Medicine and Rehabilitation, Pamukkale University
Study Record Dates
First Submitted
September 26, 2025
First Posted
January 26, 2026
Study Start
January 15, 2026
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
January 26, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share